Simple view
Full metadata view
Authors
Statistics
Generalized in vitro-in vivo relationship (IVIVR) model based on artificial neural networks
artificial neural networks
in vitro-in vivo
correlation
relationship
bioavailability
soft computing
Background: The aim of this study was to develop a generalized in vitro-in vivo relationship (IVIVR) model based on in vitro dissolution profiles together with quantitative and qualitative composition of dosage formulations as covariates. Such a model would be of substantial aid in the early stages of development of a pharmaceutical formulation, when no in vivo results are yet available and it is impossible to create a classical in vitro-in vivo correlation (IVIVC)/IVIVR. Methods: Chemoinformatics software was used to compute the molecular descriptors of drug substances (ie, active pharmaceutical ingredients) and excipients. The data were collected from the literature. Artificial neural networks were used as the modeling tool. The training process was carried out using the 10-fold cross-validation technique. Results: The database contained 93 formulations with 307 inputs initially, and was later limited to 28 in a course of sensitivity analysis. The four best models were introduced into the artificial neural network ensemble. Complete in vivo profiles were predicted accurately for 37.6% of the formulations. Conclusion: It has been shown that artificial neural networks can be an effective predictive tool for constructing IVIVR in an integrated generalized model for various formulations. Because IVIVC/IVIVR is classically conducted for 2–4 formulations and with a single active pharmaceutical ingredient, the approach described here is unique in that it incorporates various active pharmaceutical ingredients and dosage forms into a single model. Thus, preliminary IVIVC/IVIVR can be available without in vivo data, which is impossible using current IVIVC/IVIVR procedures.
dc.abstract.en | Background: The aim of this study was to develop a generalized in vitro-in vivo relationship (IVIVR) model based on in vitro dissolution profiles together with quantitative and qualitative composition of dosage formulations as covariates. Such a model would be of substantial aid in the early stages of development of a pharmaceutical formulation, when no in vivo results are yet available and it is impossible to create a classical in vitro-in vivo correlation (IVIVC)/IVIVR. Methods: Chemoinformatics software was used to compute the molecular descriptors of drug substances (ie, active pharmaceutical ingredients) and excipients. The data were collected from the literature. Artificial neural networks were used as the modeling tool. The training process was carried out using the 10-fold cross-validation technique. Results: The database contained 93 formulations with 307 inputs initially, and was later limited to 28 in a course of sensitivity analysis. The four best models were introduced into the artificial neural network ensemble. Complete in vivo profiles were predicted accurately for 37.6% of the formulations. Conclusion: It has been shown that artificial neural networks can be an effective predictive tool for constructing IVIVR in an integrated generalized model for various formulations. Because IVIVC/IVIVR is classically conducted for 2–4 formulations and with a single active pharmaceutical ingredient, the approach described here is unique in that it incorporates various active pharmaceutical ingredients and dosage forms into a single model. Thus, preliminary IVIVC/IVIVR can be available without in vivo data, which is impossible using current IVIVC/IVIVR procedures. | pl |
dc.affiliation | Wydział Farmaceutyczny : Zakład Technologii Postaci Leku i Biofarmacji | pl |
dc.affiliation | Wydział Farmaceutyczny : Zakład Farmacji Społecznej | pl |
dc.cm.date | 2020-01-07 | |
dc.cm.id | 58748 | |
dc.contributor.author | Mendyk, Aleksander - 130937 | pl |
dc.contributor.author | Tuszyński, Paweł K. | pl |
dc.contributor.author | Polak, Sebastian - 133197 | pl |
dc.contributor.author | Jachowicz, Renata - 129780 | pl |
dc.date.accessioned | 2020-01-17T07:50:18Z | |
dc.date.available | 2020-01-17T07:50:18Z | |
dc.date.issued | 2013 | pl |
dc.date.openaccess | 0 | |
dc.description.accesstime | w momencie opublikowania | |
dc.description.physical | 223-232 | pl |
dc.description.points | 35 | pl |
dc.description.version | ostateczna wersja wydawcy | |
dc.description.volume | 7 | pl |
dc.identifier.doi | 10.2147/DDDT.S41401 | pl |
dc.identifier.eissn | 1177-8881 | |
dc.identifier.project | ROD UJ / OP | pl |
dc.identifier.uri | https://ruj.uj.edu.pl/xmlui/handle/item/131473 | |
dc.language | eng | pl |
dc.language.container | eng | pl |
dc.rights | Udzielam licencji. Uznanie autorstwa - Użycie niekomercyjne 3.0 | * |
dc.rights.licence | CC-BY-NC | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/3.0/legalcode | * |
dc.share.type | otwarte czasopismo | |
dc.subject.en | artificial neural networks | pl |
dc.subject.en | in vitro-in vivo | pl |
dc.subject.en | correlation | pl |
dc.subject.en | relationship | pl |
dc.subject.en | bioavailability | pl |
dc.subject.en | soft computing | pl |
dc.subtype | Article | pl |
dc.title | Generalized in vitro-in vivo relationship (IVIVR) model based on artificial neural networks | pl |
dc.title.journal | Drug Design, Development and Therapy | pl |
dc.type | JournalArticle | pl |
dspace.entity.type | Publication |
* The migration of download and view statistics prior to the date of April 8, 2024 is in progress.
Views
17
Views per month
Views per city
Downloads
Open Access